SPECTRUM PHARMACEUTICALS INC's ticker is SPPI and the CUSIP is 84763A108. A total of 103 filers reported holding SPECTRUM PHARMACEUTICALS INC in Q1 2022. The put-call ratio across all filers is 0.24 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2023 | $588,450 | +16.2% | 612,969 | -9.2% | 0.00% | – |
| Q1 2023 | $506,527 | +19.8% | 675,369 | -41.2% | 0.00% | – |
| Q4 2022 | $422,942 | +57.8% | 1,147,738 | +84.1% | 0.00% | – |
| Q3 2022 | $268,000 | -52.4% | 623,569 | -13.6% | 0.00% | – |
| Q2 2022 | $563,000 | -86.9% | 721,769 | -78.4% | 0.00% | – |
| Q1 2022 | $4,306,000 | -28.5% | 3,338,316 | -29.6% | 0.00% | – |
| Q4 2021 | $6,024,000 | -83.9% | 4,743,039 | -72.3% | 0.00% | -100.0% |
| Q3 2021 | $37,358,000 | -11.1% | 17,136,619 | +53.0% | 0.00% | 0.0% |
| Q2 2021 | $42,000,000 | -1.9% | 11,200,031 | -14.7% | 0.00% | 0.0% |
| Q1 2021 | $42,793,000 | +18.5% | 13,126,592 | +24.0% | 0.00% | 0.0% |
| Q4 2020 | $36,101,000 | +28.6% | 10,586,684 | +53.9% | 0.00% | 0.0% |
| Q3 2020 | $28,066,000 | +22.4% | 6,878,822 | +1.4% | 0.00% | 0.0% |
| Q2 2020 | $22,935,000 | +87.4% | 6,785,536 | +29.2% | 0.00% | +100.0% |
| Q1 2020 | $12,238,000 | -30.6% | 5,252,365 | +8.5% | 0.00% | 0.0% |
| Q4 2019 | $17,625,000 | -51.1% | 4,842,001 | +11.4% | 0.00% | -66.7% |
| Q3 2019 | $36,041,000 | -18.1% | 4,344,953 | -15.0% | 0.00% | 0.0% |
| Q2 2019 | $44,008,000 | -24.2% | 5,111,276 | -5.8% | 0.00% | -40.0% |
| Q1 2019 | $58,027,000 | +13.1% | 5,428,184 | -7.4% | 0.01% | 0.0% |
| Q4 2018 | $51,291,000 | -48.9% | 5,861,781 | -1.9% | 0.01% | -37.5% |
| Q3 2018 | $100,406,000 | -9.2% | 5,976,812 | +13.3% | 0.01% | -11.1% |
| Q2 2018 | $110,570,000 | +40.9% | 5,275,272 | +8.2% | 0.01% | +28.6% |
| Q1 2018 | $78,470,000 | +0.7% | 4,876,778 | +18.6% | 0.01% | +16.7% |
| Q4 2017 | $77,931,000 | +100.9% | 4,112,737 | +49.2% | 0.01% | +100.0% |
| Q3 2017 | $38,783,000 | +72.3% | 2,756,436 | -8.7% | 0.00% | +50.0% |
| Q2 2017 | $22,507,000 | +47.1% | 3,020,563 | +28.3% | 0.00% | +100.0% |
| Q1 2017 | $15,305,000 | +113.3% | 2,353,958 | +45.3% | 0.00% | 0.0% |
| Q4 2016 | $7,177,000 | -36.5% | 1,620,307 | -33.0% | 0.00% | 0.0% |
| Q3 2016 | $11,294,000 | -11.5% | 2,419,125 | +24.6% | 0.00% | 0.0% |
| Q2 2016 | $12,759,000 | +63.6% | 1,942,050 | +58.3% | 0.00% | 0.0% |
| Q1 2016 | $7,798,000 | -53.2% | 1,226,504 | -55.6% | 0.00% | -50.0% |
| Q4 2015 | $16,665,000 | -42.9% | 2,763,699 | -43.4% | 0.00% | -33.3% |
| Q3 2015 | $29,193,000 | -14.9% | 4,881,744 | -2.6% | 0.00% | -25.0% |
| Q2 2015 | $34,297,000 | +20.9% | 5,014,140 | +7.3% | 0.00% | +33.3% |
| Q1 2015 | $28,367,000 | +21.1% | 4,672,874 | +38.2% | 0.00% | +50.0% |
| Q4 2014 | $23,433,000 | -4.9% | 3,381,609 | +11.8% | 0.00% | -33.3% |
| Q3 2014 | $24,631,000 | +8.9% | 3,025,675 | +8.7% | 0.00% | +50.0% |
| Q2 2014 | $22,625,000 | -14.3% | 2,782,779 | -17.3% | 0.00% | -33.3% |
| Q1 2014 | $26,387,000 | -51.8% | 3,365,468 | -38.4% | 0.00% | 0.0% |
| Q4 2013 | $54,762,000 | +93.8% | 5,460,133 | +62.1% | 0.00% | 0.0% |
| Q3 2013 | $28,255,000 | +6.9% | 3,367,775 | -4.9% | 0.00% | 0.0% |
| Q2 2013 | $26,423,000 | – | 3,542,188 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| ALETHEA CAPITAL MANAGEMENT, LLC | 787,973 | $615,000 | 0.77% |
| CM Management, LLC | 600,000 | $468,000 | 0.50% |
| ARMISTICE CAPITAL, LLC | 17,100,000 | $13,338,000 | 0.23% |
| Sargent Investment Group, LLC | 614,600 | $479,000 | 0.15% |
| Ergoteles LLC | 744,275 | $581,000 | 0.02% |
| Sonora Investment Management Group, LLC | 103,000 | $80,000 | 0.01% |
| CAXTON ASSOCIATES LP | 107,135 | $84,000 | 0.01% |
| MCDONALD PARTNERS LLC | 42,570 | $33,000 | 0.01% |
| Pinz Capital Management, LP | 15,600 | $12,000 | 0.01% |
| D. E. Shaw & Co., Inc. | 8,051,858 | $6,281,000 | 0.01% |